USANA Health Sciences, Inc. (N:USNA)

Sector:  Consumer Non-Cyclicals Industry:  Personal Products
See Regulatory Filings on SEC
Company Contact
Address: 3838 W Parkway Blvd
SALT LAKE CITY UT 84120-6336
Tel: N/A
IR: See website
Key People
Myron W. Wentz
Chairman of the Board
David Mulham
Chief Field Development Officer
Jim H. Brown
Kevin G. Guest
Chief Executive Officer, Director
G Douglas Hekking
Chief Financial Officer
Walter Noot
Chief Operating Officer
Daniel A. Macuga
Chief Communications and Marketing Officer
Robert A. Sinnott
Chief Scientific Officer
P. Joshua Foukas
Chief Legal Officer, General Counsel and Corporate Secretary
Paul A. Jones
Chief Leadership Development Officer
Business Overview
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.
Financial Overview
For the nine months ended 28 September 2019, USANA Health Sciences, Inc. revenues decreased 11% to $789.6M. Net income decreased 26% to $69.8M. Revenues reflect China segment decrease of 17% to $404M, Americas and Europe segment decrease of 13% to $154.7M. Net income also reflects Interest expense increase of 63% to $44K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $3.88 to $3.04.
Employees: 1,911 as of Feb 22, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $1,425M as of Sep 28, 2019
Annual revenue (TTM): $1,089M as of Sep 28, 2019
EBITDA (TTM): $165.48M as of Sep 28, 2019
Net annual income (TTM): $102.10M as of Sep 28, 2019
Free cash flow (TTM): $97.48M as of Sep 28, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 21,643,055 as of Nov 1, 2019
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization